Stock Performance Spotlight: Sunshine Biopharma Inc (SBFM) Ends the Day at 0.59, Down by -6.00

Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Sunshine Biopharma Inc’s stock clocked out at $0.59, down -6.00% from its previous closing price of $0.63. In other words, the price has decreased by -$6.00 from its previous closing price. On the day, 1.13 million shares were traded. SBFM stock price reached its highest trading level at $0.639 during the session, while it also had its lowest trading level at $0.5802.

Ratios:

To gain a deeper understanding of SBFM’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.23 and its Current Ratio is at 4.41. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 04 ’24 when Slilaty Steve N. bought 100,000 shares for $0.10 per share. The transaction valued at 10,000 led to the insider holds 130,000 shares of the business.

Slilaty Steve N. bought 20,000 shares of SBFM for $2,000 on Feb 08 ’24. The Chief Executive Officer now owns 30,000 shares after completing the transaction at $0.10 per share.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SBFM now has a Market Capitalization of 11156770 and an Enterprise Value of -5652101. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.42 while its Price-to-Book (P/B) ratio in mrq is 0.02. Its current Enterprise Value per Revenue stands at -0.211 whereas that against EBITDA is 1.362.

Stock Price History:

Over the past 52 weeks, SBFM has reached a high of $67.01, while it has fallen to a 52-week low of $0.59. The 50-Day Moving Average of the stock is -83.40%, while the 200-Day Moving Average is calculated to be -97.13%.

Shares Statistics:

It appears that SBFM traded 3.13M shares on average per day over the past three months and 2405240 shares per day over the past ten days. A total of 18.95M shares are outstanding, with a floating share count of 18.16M. Insiders hold about 4.14% of the company’s shares, while institutions hold 0.78% stake in the company. Shares short for SBFM as of 1715731200 were 176309 with a Short Ratio of 0.06, compared to 1713139200 on 69800. Therefore, it implies a Short% of Shares Outstanding of 176309 and a Short% of Float of 18.490000000000002.

Earnings Estimates

The dynamic stock of Sunshine Biopharma Inc (SBFM) is currently attracting attention from 1 analysts actively involved in rating its market status.On average, analysts expect EPS of -$0.37 for the current quarter, with a high estimate of -$0.37 and a low estimate of -$0.37, while EPS last year was -$4. The consensus estimate for the next quarter is $0.45, with high estimates of $0.45 and low estimates of $0.45.

Analysts are recommending an EPS of between $0.77 and $0.77 for the fiscal current year, implying an average EPS of $0.77. EPS for the following year is $9.99, with 1.0 analysts recommending between $9.99 and $9.99.

Revenue Estimates

For the next quarter, 1 analysts are estimating revenue of $12.6M. There is a high estimate of $12.6M for the next quarter, whereas the lowest estimate is $12.6M.

A total of 1 analysts have provided revenue estimates for SBFM’s current fiscal year. The highest revenue estimate was $44.4M, while the lowest revenue estimate was $44.4M, resulting in an average revenue estimate of $44.4M. In the same quarter a year ago, actual revenue was $24.09MBased on 1 analysts’ estimates, the company’s revenue will be $100M in the next fiscal year. The high estimate is $100M and the low estimate is $100M.

Most Popular